期刊文献+

大肠癌组织中DOC-2和c-Fos蛋白的表达

Expressions of DOC-2 and c-Fos proteins in colorectal carcinoma tissue
下载PDF
导出
摘要 目的:探讨DOC-2和c-Fos在大肠癌组织中的表达及其临床意义。方法:采用免疫组化SP法检测132例大肠癌组织及48例正常肠黏膜组织中DOC-2和c-Fos蛋白的表达情况。结果:大肠癌组织与正常肠黏膜组织中DOC-2的阳性表达率分别为31.1%(41/132)和81.2%(39/48),c-Fos的阳性表达率分别为56.1%(74/132)和12.5%(6/48),2组间差异均有统计学意义(χ2分别为35.911,27.051,P<0.001)。大肠癌组织中DOC-2的表达与患者年龄、性别、组织学类型、分化程度和临床分期无关(P>0.05),但与淋巴结及肝转移有关(P<0.05);c-Fos蛋白的表达与患者年龄、性别、组织学类型、临床分期、淋巴结及肝转移无关(P>0.05),但与分化程度有关(P<0.05)。大肠癌组织中DOC-2与c-Fos蛋白的表达呈负关联(rP=-0.368,P=0.001)。结论:DOC-2和c-Fos蛋白的异常表达可能在大肠癌的发生发展中起重要作用。 Aim:To investigate the expression and clinical significance of DOC-2 and c-Fos proteins in colorectal carcinoma tissue.Methods:The expressions of DOC-2 and c-Fos were detected by SP immunohistochemistry in samples including 132 cases of colorectal carcinoma tissue without radiotherapy or chemotherapy and 48 cases of para-carcinoma normal mucosa tissue.Results: The positive expression rate of DOC-2 was 31.1% in colorectal carcinoma,lower than that in normal mucosa tissue which was 81.2%.That of c-Fos was 56.1% in colorectal carcinoma,higher than that in normal mucosa tissue which was 12.5% (χ2 was 35.911,27.051 respectively,P0.001).The expression level of DOC-2 had no relation with age,sex,histology type,differentiated degree or clinical stage,but with lymph node and liver metastasis(P0.05).The expression of c-Fos was related to differentiated degree,but not to age,sex, histology type,clinical stage or lymph node and liver metastasis(P0.05).There was negative association between the expressions of DOC-2 and c-Fos in colorectal carcinoma tissue(r=-0.368,P=0.001).Conclusion: The imbalance of DOC-2 and c-Fos expression may play an important role in the occurrence and development of colorectal carcinoma.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2010年第6期989-992,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 大肠癌 DOC-2 C-FOS colorectal carcinoma DOC-2 c-Fos
  • 相关文献

参考文献11

  • 1Bagadi SA,Prasad CP,Srivastava A, et al. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer[ J]. Breast Cancer Res Treat ,2007,104( 3 ) : 277.
  • 2Chen H ,Toyooka S, Gazdar AF, et al. Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines [ J ]. J Biol Chem ,2003 ,278 ( 5 ) : 3 121.
  • 3Karam JA, Shariat SF, Huang HY, et al. Decreased DOC-2/ DAB2 expression in urothelial carcinoma of the bladder [ J ]. Clin Cancer Res,2007,13 ( 15 ) :4 400.
  • 4Anupam K,Tusharkant C, Gupta SD, et al. Loss of disable- 2 expression is an early event in esophageal squamous tumorigenesis [ J]. World J Gastroenterol, 2006, 12 ( 37 ) : 6 041.
  • 5Tkach V,Tulchinsky E,Lukanidin E,et al. Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility [ J ]. Oncogene, 2003,22 ( 32 ) : 5 045.
  • 6魏希锋,段建敏,曹晓锋,康永明,卢建中,史庭凯.膀胱移行细胞癌中Dab2/DOC-2与GRB2表达的相关性及临床意义[J].现代泌尿外科杂志,2009,14(5):337-339. 被引量:2
  • 7侯仁好,初晓艺,刘希双.c-Fos,c-Jun与Bcl-2蛋白在胃癌组织中的表达及意义[J].世界华人消化杂志,2006,14(24):2448-2451. 被引量:11
  • 8] Mok SC, Wong KK, Chan RK, et al. Molecular cloning of differentially expressed genes in human epithelial ovarian cancer [ J ]. Gynecol Oneol, 1994,52 (2) :247.
  • 9Xu XX, Yi T, Tang B, et al. Disabled-2 ( Dab2 ) is an SH3 domain-binding partner of Grb2 [ J ]. Oncogene, 1998, 16 (12) :1 561.
  • 10Kleeff J, Huang Y, Mok SC ,et al. Down-regulation of DOC- 2 in colorectal cancer points to its role as a tumor suppressor in this malignancy [ J ]. Dis Colon Rectum, 2002,45 (9) :1 242.

二级参考文献19

  • 1MOK SC, CHAN WY, WONG KK, et al. DOC-2,a candidate tumor suppressor gene in human epithelial ovarian cancer [J]. Oncogene, 1998, 16(18):2381-2387.
  • 2ZHOU J, FAN J, HSIEH JT. Inhibition of mitogen-elicited signal transduction and growth in prostate cancer with a small peptide derived from the functional domain of DAB2/DOC-2 delivered by a unique vehicle [J]. Cancer Res, 2006, 66(18):8954- 8958.
  • 3BAGADI SA, PRASAD CP, SRIVASTAVA A, et al. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer [J]. Breast Cancer Res Treat, 2007, 104(103): 277-286.
  • 4KLEEFF J, HUANG Y, MOK SC, et al. Down-regulation of DOC-2 in eolorectal cancer points to its role as a tumor suppressor in this malignancy [J]. Dis Colon Rectum, 2002, 45 (9): 1242-1248.
  • 5VERBEEK BS, ADRIAANSEN-SLOT SS, RIJKSEN G, et al. Grb2 overexpression in nuclei and cytoplasm of human breast cells : A histochemical and biochemical study of normal and neoplastic mammary tissue specimens[J]. J Pathol, 1997, 183(2): 195-203.
  • 6WATANABE T, SHINOHARA N, MORIYA K, et al. Signicance of the Grb2 and son of sevenless (SOS) proteins in human bladder cancer cell lines [J]. IUBMB Life, 2000, 49(4):317- 320.
  • 7YANG DH, SMITH ER, COHEN C, et al. Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity [J]. Cancer 2002, 94 (9) : 2380- 2392.
  • 8DALY RJ, BINDER MD, SUTHERLAND RL. Overexpres- sion of the Grb2 gene in human breast cancer cell lines [J]. Oncogene, 1994, 9(9) :2723-2727.
  • 9ZHOU J, HSIEH JT. The inhibitory role of DAB2/DOC-2 in growth factor receptor -mediated signal cascade [J]. J Biol Chem, 2001, 276(30):27793-27798.
  • 10LEWIS TS, SHAPIRO PS, AHN NG. Signal transduction through MAPkinase cascades [J]. Adv Cancer Rcs, 1998, 74: 49-139.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部